Covetrus Names Margie B. Pritchard General Counsel
Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Margie B. Pritchard as General Counsel and Corporate Secretary, reporting to Ben Wolin, President and Chief Executive Officer (CEO) at Covetrus.
Prior to being named as General Counsel, Pritchard most recently served as Vice President, Deputy Counsel at Covetrus, where she was responsible for corporate and board governance, public reporting, advising investor relations, employment matters including compensation, and providing general legal counsel to executive management.
“Margie has been serving as Interim General Counsel since December 2021, and we are thrilled to have her take up the post as a permanent member of our leadership team,” said Ben Wolin, President and CEO at Covetrus. “Her breadth of experience and impressive legal acumen have already proven to be invaluable, and the Company is fortunate to now more broadly benefit from her trusted guidance and demonstrated ability to help drive Covetrus’ growth.”
Pritchard brings over 30 years of experience to her role from a top-tier law firm, in-house general counsel positions and various entrepreneurial endeavors across diverse business sectors.
“I’m excited to expand my role at Covetrus,” said Margie B. Pritchard. “As a leader within the global animal-health space, Covetrus has many opportunities for growth and innovation, and I’m thrilled to have the opportunity to help drive both.”
Pritchard is a graduate of Rutgers Law School, Newark, and received a bachelor’s degree from the University of Pennsylvania.
About Covetrus
Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We are bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine with more than 5,700 employees serving over 100,000 customers around the globe. For more information about Covetrus, please visit Covetrus.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220826005045/en/
Contact information
Investor Contact
Nicholas Jansen
nicholas.jansen@covetrus.com
(207) 550-8106
Media Contact
Mona Downey
mona.downey@covetrus.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rimini Street Earns Four 2024 Top Rated Awards from TrustRadius in the Services Category8.5.2024 22:30:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP software, and a Salesforce and AWS partner, today announced that TrustRadius has recognized Rimini Street with four 2024 Top Rated Awards. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240508162325/en/ Rimini Street Earns Four 2024 Top Rated Awards from TrustRadius in the Services Category (Graphic: Business Wire) With a strong score of 9 out of 10 based on verified customer reviews, Rimini Street is recognized as a standout in the Product Implementation Services software category. Complementing this primary category, the company was top rated in additional categories, including Consulting and Advisory Services, IT Professional Services, and Managed IT Services. Since 2016, the TrustRadius Top Rated Awards have become the B2B’s industry standard f
Boomi Doubles Down on API Management with Key Acquisitions8.5.2024 18:00:00 CEST | Press release
Boomi™, the intelligent integration and automation leader, today announced the acquisitions of APIIDA’s federated API management business and API management assets from Cloud Software Group, allowing enterprises to rapidly and securely deliver business value through API products in one end-to-end platform. Both these acquisitions accelerate Boomi’s roadmap for providing solutions to the most pressing API management challenges that companies face today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240508324428/en/ Boomi Doubles Down on API Management with Key Acquisitions (Graphic: Business Wire) “APIs are the backbone of modern software and application development, and have become a cornerstone of modern architectures that enable businesses to stay agile and compete effectively,” said Steve Lucas, CEO at Boomi. “However, cloud adoption and the explosive growth of APIs have disrupted traditional IT infrastructures. With the
Boomi Unveils New Vision with Strategic Acquisitions and Latest Innovations at Boomi World 20248.5.2024 18:00:00 CEST | Press release
Boomi™, the intelligent integration and automation leader, today unveiled its vision for the company’s future, along with strategic acquisitions and key product announcements at Boomi World 2024. With more than 20,000 global customers and a network of approximately 800 partners worldwide, Boomi is leading the industry towards the future with a focus on integration and automation, API management, and data management, all made more important and powerful than ever with the emergence of the AI economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240508488304/en/ Boomi Unveils New Vision with Strategic Acquisitions and Latest Innovations at Boomi World 2024 (Graphic: Business Wire) In his keynote, Boomi CEO Steve Lucas emphasized the transformative impact of integration platform as a service (iPaaS), spotlighting its pivotal role in enhancing speed, agility, and effectiveness across business operations. Lucas explained how Bo
The smarter E AWARD 2024: Finalists Present Pioneering Solutions for a Renewable 24/7 Energy Supply8.5.2024 17:39:00 CEST | Press release
The energy industry is undergoing a radical transformation. Renewable sources of energy have become increasingly profitable in recent years and are now the most economically viable solution for generating electricity. Deployment is accelerating and the technologies are becoming increasingly sophisticated. This has put renewables in the fast lane. Visionary companies are contributing to this development with modern technologies, ideas and concepts. The best and most innovative developments have been nominated for The smarter E AWARD 2024. The prize is awarded in five categories: Photovoltaics, Energy Storage, E-Mobility, Smart Integrated Energy and Outstanding Projects. The winners will be honored on the eve of The smarter E Europe on June 18 at 6:15pm at the International Congress Center München (ICM). Europe’s largest alliance of exhibitions for the energy industry unites four exhibitions (Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe) and will take place at Me
Study Suggests Critical Link Between Residual FLT3 -ITD Mutations in Remission and Post-Transplant Outcomes in AML8.5.2024 16:00:00 CEST | Press release
A groundbreaking research study,1 sequencing DNA samples from the Pre-MEASURE study2 strongly indicates that the detection of residual FLT3 internal tandem duplication (ITD) mutations in the blood of adult subjects with acute myeloid leukemia (AML) in first complete remission (CR) is associated with worse outcomes after post allogeneic hematopoietic cell transplant (HCT). This follow-up study performed measurable residual disease (MRD) testing on DNA of 537 subjects with FLT3-ITD AML from the Pre-MEASURE study using Invivoscribe’s RUO FLT3 ITD MRD Assay kit and bioinformatics software. Its findings underscore the likely significance of residual FLT3-ITD in first CR in predicting relapse and mortality post-transplant. A key finding from this research study was that AML subjects with residual FLT3-ITD detected prior to allogeneic HCT trended towards elevated risk of relapse and mortality post-transplant, with a dose-dependent correlation within this study population. Dr. Hourigan, Direct